Akili Interactive, a leading prescription digital therapeutics company and maker of EndeavorRx®, the first and only prescription video game treatment, and Australian Securities Exchange listed digital health company TALi®, announced they have completed an agreement for Akili to license TALi’s technology designed to address early childhood attention impairments. About TALi® TALi’s patented technology utilizes new mechanisms specifically … Continue reading Akili licenses TALi technology to extend its portfolio and industry leadership